Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-29FDA Approved: ATORVASTATIN CALCIUM — Original Application (Quallent)
The FDA approved Quallent's Abbreviated New Drug Application for atorvastatin calcium, establishing a generic atorvastatin calcium product. …
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. [Phase 3]
Phase 3 trial evaluating the efficacy of Lapaquistat Acetate, alone and in combination with Ezetimibe, in adults with primary dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia [Phase 3]
A Phase 3 study evaluated the safety and efficacy of Lapaquistat Acetate alone and in combination with atorvastatin in adults with primary d…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol [Phase 3]
Phase 3 clinical trial evaluating the effect of lapaquistat acetate on blood cholesterol levels in subjects with dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. [Phase 3]
Phase 3 trial evaluating the efficacy of Lapaquistat acetate in combination with simvastatin in adults with primary dyslipidemia/hypercholes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-05-24Clinical Trial Update: Supplementation With Flaxseed Oil in the State of Rio de Janeiro [NA]
An update on a clinical trial investigating flaxseed oil supplementation for hypertension and dyslipidemia in Rio de Janeiro; no trial statu…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers [Phase 1]
Phase 1 trial to assess whether GSK256073A can block niacin-induced flushing in healthy volunteers and subjects with dyslipidemia; the study…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia [Phase 2, Phase 3]
Clinical trial update reporting efficacy and safety results for BMS-298585 alone and in combination with pravastatin in subjects with mixed …
-
CLINICAL_TRIALS research · 2012-04-20Clinical Trial Update: Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia [Phase 1, Phase 2]
This entry provides an update on a Phase 1/Phase 2 clinical trial evaluating whether oats affect lipid levels in children and adolescents wi…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Safety Study of BMS-770767 in Subjects With Hypercholesterolemia [Phase 2]
A Phase 2 safety study of BMS-770767 for hypercholesterolemia has completed.
-
CLINICAL_TRIALS research · 2012-04-16Clinical Trial Update: Longitudinal Study of Multi-Analyte Profile for Dyslipidemia [NA]
MaiHealth Inc. is conducting a longitudinal study evaluating a multi-analyte profile for dyslipidemia; the current status of the trial is un…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Cardiovascular Events Based On Statin Initiation In The Elderly
A completed clinical trial update examining cardiovascular events following statin initiation in elderly patients; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
This completed exploratory trial from GlaxoSmithKline studied the effects of two investigational drugs on body fat and inflammation in peopl…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Effect Of GW501516X On How The Heart Obtains And Uses Energy
This update reports termination of a GlaxoSmithKline trial evaluating GW501516 (Cardarine) and its effects on heart energy metabolism in dys…
-
CLINICAL_TRIALS research · 2012-03-13Clinical Trial Update: Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes
This clinical trial update reports on the prevalence of subclinical atherosclerosis and its associated factors in hyperlipidemic Korean adul…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins
An observational study evaluating outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents who are taking…
-
CLINICAL_TRIALS research · 2012-03-01Clinical Trial Update: Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia
AstraZeneca-sponsored centralized Pan-Russian survey on undertreatment of hypercholesterolemia (dyslipidemia) has completed, summarizing man…
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original application (ANDA090859) for a generic fenofibrate product, authorizing its marketi…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia [Phase 3]
Phase 3 trial comparing pioglitazone versus rosiglitazone in adults with Type 2 diabetes mellitus and dyslipidemia; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) [Phase 1]
A completed Phase 1 study evaluating lipid biomarkers in men with dyslipidemia after simvastatin treatment, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) [Phase 3]
Phase 3 long-term study of ERN/LRPT (extended-release niacin/laropiprant) for dyslipidemia completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin to simvastatin in subjects with high cholesterol was terminated.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Effect of Nigella Sativa on Lipid Profiles in Elderly [Phase 2]
Phase 2 trial assessed the effect of Nigella sativa on lipid profiles in elderly patients with dyslipidemia; the study has completed.
-
FDA approval · 2012-02-07FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the product under an ex…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Additional KIF6 Risk Offers Better Adherence to Statins
The clinical trial update indicates that providing additional KIF6 genetic risk information may improve adherence to statin therapy in patie…